Role of intracellular interleukin‐1 receptor antagonist in skin carcinogenesis

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2744|30|4|218-223

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.30, Iss.4, 2001-01, pp. : 218-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Deficient expression of aldehyde dehydrogenase 1A1 is consistent with increased sensitivity of Gorlin syndrome patients to radiation carcinogenesis

By  

Molecular Carcinogenesis, Vol. 54, Iss. 6, 2015-06 ,pp. : 473-484

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic analysis of colon tumors induced by a dietary carcinogen PhIP in CYP1A humanized mice: Identification of mutation of β‐catenin/Ctnnb1 as the driver gene for the carcinogenesis

By  

Molecular Carcinogenesis, Vol. 54, Iss. 11, 2015-11 ,pp. : 1264-1274

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel mechanism of skin tumor promotion involving interferon‐gamma (IFNγ)/signal transducer and activator of transcription‐1 (Stat1) signaling

By  

Molecular Carcinogenesis, Vol. 54, Iss. 8, 2015-08 ,pp. : 642-653

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting the insulin‐like growth factor‐1 receptor by picropodophyllin for lung cancer chemoprevention

By  

Molecular Carcinogenesis, Vol. 54, Iss. S1, 2015-06 ,pp. : E129-E137

John Wiley & Sons Inc

Access to resources Recommend Favorite

The chemokine receptor CX3CR1 coordinates monocyte recruitment and endothelial regeneration after arterial injury

By  

EMBO Molecular Medicine, Vol. 10, Iss. 2, 2018-02 ,pp. : 151-159

John Wiley & Sons Inc

Access to resources Recommend Favorite